Ryan F. Donnelly
- Pharmaceutical Science top 0.01%
- Advancements in Transdermal Drug Delivery 304
- Advanced Drug Delivery Systems 141
- Dermatology top 0.01%
- Dermatology and Skin Diseases 128
- Contact Dermatitis and Allergies 29
- Molecular Medicine top 0.2%
- Biomaterials top 0.2%
- Insect Science top 0.1%
-
- Photodynamic Therapy Research Studies 57
-
- Ocular Surface and Contact Lens 52
-
- Lipid Membrane Structure and Behavior 32
-
- Nanoplatforms for cancer theranostics 24
- Co-authors
- Eneko LarrañetaA. David WoolfsonThakur Raghu Raj SinghMaelíosa McCruddenPaul A. McCarronHelen O. McCarthyLalitkumar K. VoraAaron J. Courtenay
- Journals
- International Journal of Pharmaceutics (62 papers)Journal of Controlled Release (36 papers)Drug Delivery and Translational Research (27 papers)
- Partner nations
- United KingdomIndonesiaSpain
In The Last Decade
Ryan F. Donnelly
457 papers receiving 27.4k citations
Hit Papers
Peers
Comparison fields: 5 of 184
- Pharmaceutical Science 18.6k
- Dermatology 8.8k
- Molecular Medicine 1.0k
- Biomaterials 2.4k
- Insect Science 2.1k
Countries citing papers authored by Ryan F. Donnelly
This map shows the geographic impact of Ryan F. Donnelly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan F. Donnelly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan F. Donnelly more than expected).
Fields of papers citing papers by Ryan F. Donnelly
This network shows the impact of papers produced by Ryan F. Donnelly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan F. Donnelly. The network helps show where Ryan F. Donnelly may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ryan F. Donnelly, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 5 | |
| 3 | 2024 | 6 | |
| 4 | 2024 | 15 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 6 | |
| 7 | 2024 | 11 | |
| 8 | 2024 | 4 | |
| 9 | 2024 | 2 | |
| 10 | 2024 | 5 | |
| 11 | 2023 | 4 | |
| 12 | 2023 | 1 | |
| 13 | 2023 | 5 | |
| 14 | 2023 | 0 | |
| 15 | 2023 | 27 | |
| 16 | 2022 | 23 | |
| 17 | On a highway to the brain: A review on nose-to-brain drug delivery using nanoparticlesbreakdown → | 2022 | 173 |
| 18 | 2021 | 27 | |
| 19 | 2020 | 156 | |
| 20 | 2019 | 110 |
About Ryan F. Donnelly
Ryan F. Donnelly is a scholar working on Pharmaceutical Science, Dermatology, Molecular Medicine, Biomaterials and Virology, having authored 479 papers that have together received 27.8k indexed citations. Recurring topics across this work include Advancements in Transdermal Drug Delivery (304 papers), Advanced Drug Delivery Systems (141 papers), Dermatology and Skin Diseases (128 papers), Photodynamic Therapy Research Studies (57 papers), Ocular Surface and Contact Lens (52 papers), Lipid Membrane Structure and Behavior (32 papers), Contact Dermatitis and Allergies (29 papers) and Nanoplatforms for cancer theranostics (24 papers). The work is most often cited by research in Pharmaceutical Science (18.6k citations), Dermatology (8.8k citations), Molecular Medicine (1.0k citations), Biomaterials (2.4k citations) and Insect Science (2.1k citations). Ryan F. Donnelly has collaborated with scholars based in United Kingdom, Indonesia and Spain. Frequent co-authors include Eneko Larrañeta, A. David Woolfson, Thakur Raghu Raj Singh, Maelíosa McCrudden, Paul A. McCarron, Helen O. McCarthy, Lalitkumar K. Vora, Aaron J. Courtenay, Martin J. Garland and Juan Domínguez‐Robles. Their work appears in journals such as International Journal of Pharmaceutics, Journal of Controlled Release, Drug Delivery and Translational Research, European Journal of Pharmaceutics and Biopharmaceutics and Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.